Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone?secreting pituitary adenomas

被引:6
|
作者
Kim, Soo Heon [1 ]
Ku, Cheol Ryong [2 ,3 ,4 ]
Na, Minkyun [1 ]
Yoo, Jihwan [1 ]
Kim, Woohyun [1 ]
Jung, In-Ho [1 ]
Kim, Kyung Won [2 ]
Moon, Ju Hyung [1 ,3 ,4 ]
Kim, Daham [2 ,3 ,4 ]
Lee, Eun Jig [2 ,3 ,4 ]
Kim, Sun Ho [1 ,5 ]
Kim, Eui Hyun [1 ,3 ,4 ]
机构
[1] Yonsei Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul, South Korea
[3] Severance Hosp, Pituitary Tumor Ctr, Seoul, South Korea
[4] Yonsei Univ, Yonsei Endocrine Res Inst, Coll Med, Seoul, South Korea
[5] Ewha Womans Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
关键词
hyperthyroidism; pituitary adenoma; remission; thyroid-stimulating hormone; transsphenoidal surgery; pituitary surgery;
D O I
10.3171/2020.1.JNS192787
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare type of pituitary adenoma; thus, little is known about TSHomas. The purpose of this study was to analyze clinical characteristics and therapeutic outcomes of TSHomas based on a single-center experience. The authors also searched for reliable preoperative and early postoperative factors that could predict long-term endocrinological remission. METHODS The clinical, radiological, and pathological characteristics and surgical and endocrinological outcomes of 31 consecutive cases of TSHomas that were surgically treated between 2005 and 2017 were reviewed retrospectively. Preoperative factors were evaluated for their ability to predict long-term remission by comparing remission and non remission groups. TSH and free thyroxine levels were measured at 2, 6, 12, 18, and 24 hours after surgery to determine whether they could predict long-term remission. RESULTS Gross-total removal of tumor was achieved in 28 patients (90.3%), and 26 patients (83.9%) achieved endocrinological remission by surgery alone based on long-term endocrinological follow-up (median 50 months, range 32-81 months). The majority of the tumors were solid (21/31, 67.7%), and en bloc resection was possible in 16 patients (51.6%). Larger tumor size and tumor invasion into cavernous sinus and sphenoid sinus were strong predictors of lower rates of endocrinological remission. Immediate postoperative TSH level at 12 hours after surgery was the strongest predictor, with a 0.62 mu IU/mL cutoff. Postoperative complications included CSF rhinorrhea in one patient and epistaxis in another patient, who underwent additional surgical treatment for the complications. CONCLUSIONS Tumor size and extent are major prognostic factors for both extent of resection and endocrinological remission. The consistency of TSHomas was more likely to be solid, which makes extracapsular dissection more feasible. Long-term remission of TSHomas could be predicted even during the early postoperative period. https://thejns.org/doi/abs/10.3171/2020.1.JNS192787
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [21] Clinical use of sensitive assays for thyroid-stimulating hormone
    Masters, PA
    Simons, RJ
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (02) : 115 - 127
  • [22] Thyroid-stimulating hormone levels in children from Chernobyl
    Quastel, MR
    Goldsmith, JR
    Mirkin, L
    Poljak, S
    Barki, Y
    Levy, J
    Gorodischer, R
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 1497 - 1498
  • [23] Thyroid-Stimulating Hormone and Estimated Glomerular Filtration Rate
    Iqbal, Sameena
    Barama, Dalila
    Yang, Davine
    Zand, Khashayar Rafat
    Scheede-Bergdahl, Celena
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 12 (03) : 89 - 96
  • [24] Thyroid function in early pregnancy I: Thyroid-stimulating hormone response to thyrotropin-releasing hormone
    De Leo, V
    la Marca, A
    Lanzetta, D
    Morgante, G
    GYNECOLOGICAL ENDOCRINOLOGY, 1998, 12 (03) : 191 - 196
  • [25] HYPERTHYROIDISM DUE TO INAPPROPRIATE SECRETION OF THYROID-STIMULATING HORMONE - DIAGNOSIS AND MANAGEMENT
    HERMUS, A
    ROSS, H
    VANLIESSUM, P
    NABER, A
    SMALS, A
    KLOPPENBORG, P
    NETHERLANDS JOURNAL OF MEDICINE, 1991, 38 (5-6): : 193 - 198
  • [26] Importance of thyroid-stimulating hormone levels in liver disease
    Kim, Hyun Jin
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (09): : 1133 - 1137
  • [27] Trauma and thyroid-stimulating hormone abnormalities in pediatric patients
    Aggarwal, Shefali
    Fogel, Joshua
    Kumar, Krishan
    Shabbir, Nadeem
    TRAUMA-ENGLAND, 2020, 22 (02): : 118 - 125
  • [28] The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma
    Shi, Rong-liang
    Liao, Tian
    Qu, Ning
    Liang, Fei
    Chen, Jia-ying
    Ji, Qing-hai
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 154 (02) : 256 - 262
  • [29] THYROID-FUNCTION AND RELEASE OF THYROID-STIMULATING HORMONE AND PROLACTIN FROM THE PITUITARY IN HUMAN OBESITY
    SCAGLIONE, R
    AVERNA, MR
    DICHIARA, MA
    BARBAGALLO, CM
    MAZZOLA, G
    MONTALTO, G
    LICATA, G
    NOTARBARTOLO, A
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1991, 19 (05) : 389 - 394
  • [30] The Effect of Thyroid-Stimulating Hormone on Tumor Size in Differentiated Thyroid Carcinoma
    Ozemir, I. A.
    Gurbuz, B.
    Bayraktar, B.
    Aslan, S.
    Baskent, A.
    Yalman, H.
    Yigitbasi, R.
    Alimoglu, O.
    INDIAN JOURNAL OF SURGERY, 2015, 77 : S967 - S970